According to the provisions of the State Food and Drug Administration, starting from October 1, 2007, all pharmaceutical companies must use new packaging when producing drugs, otherwise they may not be listed for sale. “From the current point of view, changing packaging may have a big impact on pharmaceutical companies, but this is only a painful process in the process of regulating the industry.†Industry insiders believe. 
According to the “Manifesto and Label Management Regulations†promulgated by the State Food and Drug Administration in 2006, starting from October 1, 2007, all pharmaceutical companies must use new packaging when producing pharmaceuticals. The trademarks and trade names must not be larger than the common name, otherwise they cannot IPO.
Recently, the reporter visited several large pharmacies in Beijing and discovered that some medicines placed on shelves have been used in new packaging, and the common names on new packaging are all obvious. For example, for some cold medicines, on the packaging, in addition to the names “Crack†and “Seikangâ€, the words “Compound Aminophenolamine†are also printed in the conspicuous place; Niuhuang Xiaoyan Tablets, and “Jiaheng†are obviously trademarks. Less than generic drug name number; "New Contac" font has been reduced, and its common name "complex pharmacokinetics pseudoephedrine sustained-release capsule" is enlarged. However, there are still many medicines on the shelf that remain the same, placing the drug's trade name in the most obvious position.
"It will take some time for medicines to be completely replaced with new ones, because the old packaging medicines have not yet been sold out," said a person familiar with the Beijing Jingwei Pharmacy.
Drugs must use common names
It is understood that currently the same drug is usually produced by multiple manufacturers. Many drug manufacturers often register their own drugs with unique trade names in order to establish their own brand. As a result, medicines containing the same chemical composition have various drug names due to different manufacturers and dosage forms, making people dazzled. This not only causes confusion to the people, but also causes repeated drug use for patients who lack knowledge of drugs. Get drugs wrongly.
For this reason, Article 25 of the "Management Notes and Label Management Regulations" stipulates that in the new packaging of drugs, the common name should be prominent and prominent, and its font, font size, and color must be the same and meet the following requirements: The horizontal label must be Marked in a prominent position in the upper 1/3 range; vertical labels should be marked in a prominent position in the right 1/3 range; not easily recognized in cursive script, regular script, etc.; font color should be black or white, and corresponding shallow The color or dark background forms a strong contrast. In addition, the drug product name must not be written in conjunction with the generic name. Its font and color must not be more prominent and prominent than the generic name. Its font size must not be greater than 1/2 of the font used for the common name in single-word area.
"The "provision" is precisely for some pharmaceutical companies deliberately fooled consumers with some novel product names, and took the opportunity to raise prices." Industry analysts believe that after the "Regulations" are implemented, this phenomenon will be effectively curbed.
People have different reactions
In the interview, the reporter found that although the introduction of the policy was to provide affordable measures for the use of drugs by the common people, the people's response was not consistent.
Many citizens welcomed the "Regulations" and believed that the number of new drugs is too numerous to count and the drugs are indistinguishable. The prices are very expensive. Drugs with the same composition often have different prices due to different names. When buying drugs, doctors and pharmacy staff recommended it, often spending more money.
"Actually, every drug has a legal name determined according to its chemical composition, which is the generic name of the drug." Experts said that because the same chemical composition of the drug may be produced by different manufacturers, some companies in order to make their own Products are distinguished from other manufacturers by giving their products a trade name or registering a trademark. This can easily lead to consumer misuse and repeated drug use.
"I didn't know what 'amoxicillin' was before, but now I know it's actually an antibiotic like 'amoxicillin'." Ms. Lin, who bought medicine at a pharmacy, told reporters, "Now the drug has a common name. Buying drugs only memorizes common names, which is much more convenient."
In the interview, some old people said that the original drug name was better remembered, but the current name is too long and not easy to remember. "The original drug name has been called for more than a decade. Now it has changed to another name. It's really not a habit."
"The names of phenol alkylamine capsules, ibuprofen sustained-release capsules, and compound aminophenol alkylamine tablets are indeed more difficult to remember for older people," the pharmacy's staff reported.
“Unified drug names should be more convenient for pharmacies, hospitals, and consumers. In the past, because the same drugs had several or even dozens of different product names, it was troublesome for doctors to write prescriptions for many drug names. “The staff member believes that “the drug identification is now clearer, consumers are clear at the time of purchase, and drug acceptance is naturally higher.â€
After the new drug packaging is completed
With regard to the coexistence of old and new pharmaceutical packaging appearing in the market, the relevant person in charge of the State Food and Drug Administration explained that there is a transitional period for the implementation of the “Regulationsâ€, and October 1 is the deadline for production after October 1. The pharmaceutical packaging must be implemented in accordance with the new regulations, but the previously produced pharmaceutical packaging is also allowed to circulate if it meets the original regulations.
It is reported that if the packaging of medicines produced after October 1st is not regulated, relevant departments will impose penalties in accordance with relevant regulations. Yan Jiangxi, a spokesperson for the State Food and Drug Administration, made it clear that if a pharmaceutical company fails to change its packaging according to the regulations, according to Article 54 of the Drug Administration Law, if the circumstances are serious, the approval document for the drug may be revoked.
When several or even more than a dozen drugs all appear on a drug holder with similar faces, does the previous publicity of a single drug not be wasted? Pharmaceutical companies how to deal with? The person in charge of the drug company told reporters that in addition to paying more attention to the promotion of corporate brands, drug companies will also increase the advertising of terminals, such as placing pamphlets in pharmacies, allowing people to have more To understanding.
“From the current point of view, changing packaging may have a big impact on pharmaceutical companies, but this is only a source of pain in the process of regulating the industry.†Industry analysts believe.
In the interview, relevant person in charge of several pharmacies expressed their firm implementation and implementation of the state's regulations and policies. They will never purchase medicines that were produced after October 1st but have not been changed. The pharmacy will also provide relevant training for employees so that the staff can accurately answer consumers' questions about new drug packaging and actively remind consumers to purchase new packaged drugs.